What is Spinal muscular atrophy with respiratory distress type 1

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare, severe genetic disorder characterized by progressive muscle weakness and early-onset respiratory failure due to diaphragmatic paralysis. It is caused by mutations in the IGHMBP2 gene and typically presents in infancy with life-limiting symptoms requiring specialized respiratory support.

What causes Spinal muscular atrophy with respiratory distress type 1?

Spinal muscular atrophy with respiratory distress type 1 is an autosomal recessive condition, meaning a child must inherit one mutated IGHMBP2 gene from each parent. This gene is responsible for producing a protein involved in DNA replication and cellular repair. When this protein is dysfunctional, it specifically affects the alpha motor neurons in the spinal cord, leading to the rapid degeneration of nerves that control muscles and the diaphragm.

What are the primary symptoms and body systems affected?

While Spinal muscular atrophy with respiratory distress type 1 primarily impacts the motor neurons, it manifests through several distinct clinical features:

• Respiratory failure: Often the first sign, characterized by diaphragmatic weakness resulting in rapid, shallow breathing.


• Distal muscle weakness: Initial weakness often begins in the hands and feet before progressing to the rest of the body.


• Autonomic dysfunction: Patients may experience urinary retention, excessive sweating, or cardiac arrhythmias.


• Joint contractures: Developing early, these limit the range of motion in limbs.

How common is this condition?

Spinal muscular atrophy with respiratory distress type 1 is extremely rare, with an estimated prevalence of less than 1 in 1,000,000 individuals worldwide. Because the condition is often misdiagnosed as other forms of spinal muscular atrophy, the exact number of cases is difficult to track. Currently, 47 people with Spinal muscular atrophy with respiratory distress type 1 have joined the DiseaseMaps.org community to share their experiences and support one another.

How is this different from other types of SMA?

Unlike classic Spinal Muscular Atrophy (SMA), which is caused by SMN1 gene mutations and typically affects proximal muscles first, Spinal muscular atrophy with respiratory distress type 1 is distinguished by its primary impact on the diaphragm and its distal-to-proximal progression of muscle weakness. The specific involvement of the IGHMBP2 gene is the definitive diagnostic marker that separates this condition from other motor neuron diseases.

Next steps

• Consult a pediatric neurologist or a geneticist for definitive molecular testing of the IGHMBP2 gene.


• Connect with the 47 members of our community at DiseaseMaps.org for peer-to-peer emotional support.


• Work with a multidisciplinary care team, including pulmonologists and physical therapists, to manage respiratory and mobility needs.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Spinal muscular atrophy with respiratory distress type 1 (ORPHA:3245)


• NIH GARD: Spinal muscular atrophy with respiratory distress type 1


• OMIM: IGHMBP2-related disorders (#604320)


• PubMed: Clinical and molecular features of SMARD1